The shares of DXC Technology Company (NYSE:DXC) started off the last trading session with the price of $105.8 while closing the day with the price of $107.31. The shares of DXC Technology Company (NYSE:DXC) Rise 1.48% with the Gain of 1.51 points.
The shares of DXC Technology Company (NYSE:DXC) traded with the day volume of 1.86 Million shares whereas its average trading volume is 1.62 Million.
While analyzing the past performance of the stock we can see that the shares of DXC Technology Company (NYSE:DXC) Gain 1.2% in the last week while rising 6.44% in the last month. Past quarter performance shows the green light with 12.66%. The semi-annual and annual performance shows 26.47% and 60.76% respectively.
Some critical values of the shares of DXC Technology Company (NYSE:DXC) to be discussed here are: the beta which shows the value at 0.9 while Average True Range of DXC Technology Company (NYSE:DXC) demonstrate the value at 2.33. The weekly and monthly volatility of the shares of DXC Technology Company (NYSE:DXC) are indicated at 1.80% and 2.09%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 65.3.
While studying the financial position of the shares of DXC Technology Company (NYSE:DXC), we can see that the Market capitalization of the company is at 30.64 Billion. The shares outstanding for the company is 285.5 Million and the shares float stands at 284.75 Million. The income of the company stand at 723 Million while the sales stand at 20.15 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 1.96, Price to Earnings or P/E is at 54.78, Price to Sales P/S show the value of 1.52, the Return on Asset ROA stood at 0.039 and the Return on Equity ROE depicted at 0.107 while Return on Investment ROI is at -0.021.
Celldex Therapeutics, Inc. (NASDAQ:CLDX)
Celldex Therapeutics, Inc. (NASDAQ:CLDX) started its previous trading session at $2.41 and closed at $2.43 showing a Rise of 1.67 Percent.
The Company traded with an average Volume of 1.35 Million whereas, its Day Volume stood at 1.86 Million.
Looking at the performance of the stock, Celldex Therapeutics, Inc. (NASDAQ:CLDX) Loss -5.81% in the last week in its shares price and 3.4% in the last month. Quarterly performance shows a red of -18.18 Percent while Semi-Annual and Annual performances shows a -3.95 and -27.89 percent respectively.
Beta for Celldex Therapeutics, Inc. (NASDAQ:CLDX) stands at 2.53 while the ATR (average true range) is at 0.13. The Stock’s Weekly and Monthly Volatility is 5.36% and 5.31% respectively showing a RSI value of 45.19.
While studying the financial position of the shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX), we can see that the Market capitalization of the company is at 333.13 Million. The shares outstanding for the company is 137.09 Million and the shares float stands at 135.15 Million.
The Company generated an income of -112100000 and the sales of 12.7 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.88 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 26.23 respectively.
The Return on Assets stands at -0.277, ROE shows a value of -0.398 and ROI for Celldex Therapeutics, Inc. (NASDAQ:CLDX) is -0.492 as of Trailing Twelve Months period.